HUM-MOLGEN events: EASL Monothematic Conference “Evaluation of Disease Severity and Prognosis in Chronic Liver Disease”

THURSDAY, JANUARY 27, 2011

16.00 – 19.00 Registration

FRIDAY, JANUARY 28, 2011

Introduction

08:15 - 08:30	Opening Remarks and Introduction Laurent Castera, France and Massimo Pinzani, Italy
08:30 - 10:30	Session 1: The Pathophysiology of Disease Progression in Chronic Liver Diseases Chairs: Scott L. Friedman, USA and Massimo Pinzani, Italy
8:30	Tissue Damage, Inflammation and Fibrosis Scott L. Friedman, USA
9:00	Origin and Development of Hepatocellular Carcinoma Massimo Levrero, Italy
9:30	Portal Hypertension Guadalupe Garcia-Tsao, USA
10:00	Reversibility of Fibrosis John P. Iredale, UK
10:30 - 11:00	Coffee Break and Poster Viewing
11:00	Session 2: Are There “Gold” or “Best” Standards? Chairs: Andrew K. Burroughs, UK and Pierre Bedossa, France
11:00	Liver Biopsy: The Pathologist Perspective Tania Roskams, Belgium
11:30	Liver Biopsy: The Clinician Perspective Dominique-Charles Valla, France
12:00	How can Pathological Scores be Improved? Pierre Bedossa, France
12:30	HVPG: Technical Issues and Clinical Relevance Juan G. Abraldes, Spain
13:00 - 14:00	Lunch Break and Poster Viewing
14:00 - 16:00	Session 3: Non Invasive Assessment of Liver Disease Severity: Currently Available Tools Chairs: Detlef Schuppan, USA and Thierry Poynard, France
14:00	Endpoints and Clinical Needs Massimo Pinzani, Italy
14:30	Serum Markers (Indirect and Direct) Nezam Afdhal, USA
15:00	Transient Elastography Laurent Castera, France
15:30	Imaging Techniques (US, CT, MRI, and ARFI) Bernard van Beers, France
16:00 - 16:30	Coffee Break and Poster Viewing
16:30 - 18:30	Session 4: Non Invasive Assessment of Liver Disease Severity: Clinical Use Chairs: Alfredo Alberti, Italy and Laurent Castera, France
16:30	Viral Hepatitis Alfredo Alberti, Italy
17:00	HIV Co-infection Vincent Soriano, Spain
17:30	NAFLD and Alcoholic Liver Disease Christopher Day, UK
18:00	Auto-immune and Cholestatic Liver Diseases and Post-OLT Xavier Forns, Spain
18:30	Welcome Reception

SATURDAY, JANUARY 29, 2011

09:00 - 10:00	Session 5: Novel Techniques Chairs: Peter Jansen, The Netherlands and Massimo Levrero, Italy
9:00	Genetic Markers Ramon Bataller, Spain
9:30	MIRNAS in Liver Fibrosis Christian Trautwein, Germany
10:00 - 10:30	Coffee Break and Poster Viewing
10:30 - 12:30	Session 6: Diagnostic and Prognostic Markers in Patients with Cirrhosis Chairs: Roberto de Franchis, Italy and Didier Samuel, France
10:30	Compensated Cirrhosis Mauro Bernardi, Italy
11:00	Occurrence of HCC in Cirrhosis Markus Peck, Austria
11:30	Should we Reconsider CHILD-PUGH and MELD? Andrew K. Burroughs, UK
12:00	Novel Development to Assess Severity and Progression Detlef Schuppan, USA
12:30 - 14:00	Lunch Break and Poster Viewing
14:00 - 16:30	Session 7: Disease Regression and Impact of Treatment Chairs: Antonio Craxi, Italy and Jean-Michel Pawlotsky, France
14:00	How to Evaluate Disease Regression? Didier Samuel, France
14:30	Viral Hepatitis and HIV Co-infection Massimo Puoti, Italy
15:00	NAFLD Helena Cortez-Pinto, Portugal
15:30	Alcoholic Liver Disease Philippe Mathurin, France
16:00	Auto-immune and Cholestatic Liver Diseases Ulrich Beuers,The Netherlands
16:30 - 17:00	General Discussion and Conclusions Laurent Castera, France and Massimo Pinzani, Italy

EASL Monothematic Conference “Evaluation of Disease Severity and Prognosis in Chronic Liver Disease”

Timetable

THURSDAY, JANUARY 27, 2011

FRIDAY, JANUARY 28, 2011

Introduction

SATURDAY, JANUARY 29, 2011

Registration fees (in Euro, inclusive of 19.6% VAT) :